Literatur
- 1
Mullis P E, Tonella P.
Regulation of fetal growth: consequences and impact of being born small.
Best Pract Res Clin Endocrinol Metab.
2008;
22
173-190
- 2
Verkauskiene R, Figueras F, Deghmoun S. et al .
Birth weight and long-term metabolic outcomes: does the definition of smallness matter?.
Horm Res.
2008;
70
309-315
- 3
Dalziel S R, Parag V, Rodgers A. et al .
Cardiovascular risk factors at age 30 following pre-term birth.
Int J Epidemiol.
2007;
36
907-915
- 4
Hindmarsh P C, Geary M P, Rodeck C H. et al .
Intrauterine growth and its relationship to size and shape at birth.
Pediatr Res.
2002;
52
263-268
- 5
Gluckman P D, Hanson M A, Cooper C. et al .
Effect of in utero and early-life conditions on adult health and disease.
N Engl J Med.
2008;
359
61-73
- 6
Saenger P, Czernichow P, Hughes I. et al .
Small for gestational age: short stature and beyond.
Endocr Rev.
2007;
28
219-251
- 7
Goldenberg N, Barkan A.
Factors regulating growth hormone secretion in humans.
Endocrinol Metab Clin North Am.
2007;
36
37-55
- 8 Kelnar C JH, Savage M O, Saenger P, Cowell C T, eds. Growth disorders. 2nd ed. London;
Hodder Arnold 2000
- 9
Laron Z, Bidlingmaier M, Strasburger C J.
Indications, limitations and pitfalls in the determination of human growth hormone,
IGF-I and their binding proteins.
Pediatr Endocrinol Rev.
2007;
5 (Suppl. 1)
555-569
- 10
Bidlingmaier M, Strasburger C J.
What endocrinologists should know about growth hormone measurements.
Endocrinol Metab Clin North Am.
2007;
36
101-108
- 11 Jones K L, ed. Smith recognizable patterns of human malformation. 6th ed. Philadelphia;
Elsevier Sanders 2006
- 12
Habashi J P, Judge D P, Holm T M. et al .
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
Science.
2006;
312
117-121
Prof. Dr. Primus-E. Mullis
Pädiatrische Endokrinologie, Diabetologie & Metabolik
Universitäts-Kinderklinik
Inselspital
3010 Bern
Phone: 031/632 95 50
Fax: 031/632 95 52
Email: primus.mullis@insel.ch
